Publication | Closed Access

MDG-1, an Ophiopogon polysaccharide, restrains process of non-alcoholic fatty liver disease via modulating the gut-liver axis

Metabolic SyndromeHepatologyBiochemistryOphiopogon PolysaccharideMedicineLiver PhysiologyGut-liver AxisGlycobiologyHepatotoxicityLiver DiseaseFatty Liver DiseaseMetabolismPharmacologyGastrointestinal Peptide HormoneHealth Sciences